Anhui Anke Biotechnology (Group) Co., Ltd. (300009.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap15.99B
Enterprise Value15.77B
P/E Ratio21.54
PEG Ratio-9.26
Price/Sales Ratio5.86
Price/Book Ratio3.16
Enterprise/Revenue5.81
Enterprise/EBITDA17.2

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.27
Operating Margin0.3
AD

Management Effectiveness

Return On Assets0.12
Return On Equity0.16

Income Statement

Revenue2.65B
Revenue/Share1.53
Gross Profit2B
EBITDA959.03M
Net Income735.19M
Diluted EPS0.44

Balance Sheet

Total Cash1.66B
Total Cash/Share0.99
Total Debt57.43M
Total Debt/Equity0.01
Current Ratio4.3
Book Value Per Share2.94

Price History

52-Week Change-22.61
52-Week High12.36
52-Week Low7.35
Moving Average 50 Days8.27
Moving Average 200 Days9.23

Statistics

Average Volume26.59M
Shares Outstanding1.67B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.25
Trailing Annual Dividend Yield2.79
Payout Ratio0.37
Last Split Factor6:5
Last Split DateMay 14, 2021
AD